A Study of Barzolvolimab in Patients With Atopic Dermatitis

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT07256392 ·Status: RECRUITING ·Phase: PHASE3

A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

NCT05368285 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

NCT04762277 ·Status: COMPLETED ·Phase: PHASE2

A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

NCT05405660 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis

NCT03496974 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Omalizumab in Bullous Pemphigoid

NCT00472030 ·Status: COMPLETED ·Phase: PHASE4

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

NCT05774184 ·Status: COMPLETED ·Phase: PHASE2

The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid

NCT04465292 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

NCT00691873 ·Status: COMPLETED ·Phase: PHASE4

Rituximab in the Treatment of Patients With Bullous Pemphigoid

NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

NCT04206553 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

NCT04612790 ·Status: TERMINATED ·Phase: PHASE3

Anti-IL-5 Therapy in Bullous Pemphigoid (BP)

NCT01705795 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 ·Status: RECRUITING ·Phase: PHASE1

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

NCT05322473 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

NCT07262983 ·Status: RECRUITING ·Phase: PHASE1

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

NCT00329381 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

NCT06015308 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

NCT03055195 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa

NCT04019041 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)

NCT00777764 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06411899 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

NCT01688882 ·Status: TERMINATED ·Phase: PHASE2

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06046729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2